IGFALS / ALS antibody
Principal name
IGFALS / ALS antibody
Alternative names for IGFALS / ALS antibody
Insulin-like growth factor-binding protein complex acid labile chain
Ncbi ID
9606, NP_004961, AAH25681.1, NP_004961.1, NP_032366.2, NM_053329, NM_004970, NM_001146006
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of IGFALS / ALS antibody
- Kit Component:
- - KN308177G1, Igfals gRNA vector 1 in pCas-Guide vector
- KN308177G2, Igfals gRNA vector 2 in pCas-Guide vector
- KN308177D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Human Brain; WB Suggested Anti-IGFALS Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human brain; IGFALS antibody - middle region (ARP42206_P050) in Human Brain cells using Western Blot

Transfected 293T; WB Suggested Anti-IGFALS Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Transfected 293T; IGFALS antibody - middle region (ARP42207_P050) in Transfected 293T cells using Western Blot

Western blot analysis of ALS expression in HEK293T (A); mouse liver (B); rat kidney (C) whole cell lysates.

Western blot analysis of extracts from COLO205 cells, using IGFALS antibody.The lane on the right is treated with the synthesized peptide.

WB Suggested Anti-IGFALS Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 1562500; Positive Control: Transfected 293T
CRISPR
Catalog No. | Species | Donor Vector | |
---|---|---|---|
KN206542RB | IGFALS - human gene knockout kit via CRISPR |
||
![]() |
Human | RFP-BSD |
1 kit /
€1,290.00
|
OriGene Technologies, Inc. |